ocular drug delivery

Pharma

Glaukos beats path to FDA after eye implant trials hit goals

Glaukos found the implant was non-inferior to an active control, twice-daily topical timolol ophthalmic solution, in glaucoma and ocular hypertension.

Nick Paul Taylor Sep 13, 2022 8:45am

Glaukos pays iVeena $10M for eye drop vision loss candidate

Aug 30, 2022 10:05am

Kala buys time by selling eye disease drugs to Alcon for $60M

May 24, 2022 10:35am

Salvat heads to regulators with phase 3 data on ocular steroid

Apr 12, 2022 7:34am

Optifye and DelSiTech partner on controlled-release eye drops

Mar 29, 2022 7:50am

MediPrint raises cash to advance drug delivery contact lens

Mar 22, 2022 7:45am